XML 26 R14.htm IDEA: XBRL DOCUMENT
v3.21.1

Earnings per Share | 3 Months Ended
--- | ---
May 01, 2021
Earnings Per Share [Abstract] |
Earnings per Share | 7. Earnings per Share The following table provides a reconciliation of the number of shares outstanding for basic and diluted earnings per share:
|  | For the three months ended |  |
|  | May 1, 2021 |  |  | May 2, 2020 |  |
(in thousands) |  |  |  |  |  |  |  |  |
Common stock outstanding: |  |  |  |  |  |  |  |  |
Basic weighted average common shares outstanding |  |  | 62,153 |  |  |  | 50,758 |  |
Common stock equivalents – stock options, restricted stock units and deferred stock (1) |  |  | 847 |  |  |  | — |  |
Diluted weighted average common shares outstanding |  |  | 63,000 |  |  |  | 50,758 |  |
| (1) | Common stock equivalents of 261 shares for the three months ended May 2, 2020 were excluded due to the net loss.
The following potential common stock equivalents were excluded from the computation of diluted earnings per share in each period, because the exercise price of such options was greater than the average market price per share of common stock for the respective periods or because the unearned compensation associated with stock options, restricted stock units, or deferred stock had an anti-dilutive effect.
|  | For the three months ended |  |
|  | May 1, 2021 |  |  | May 2, 2020 |  |
(in thousands, except exercise prices) |  |  |  |  |  |  |  |  |
Stock options |  |  | 1,933 |  |  |  | 538 |  |
Restricted stock units |  |  | 506 |  |  |  | 963 |  |
Deferred stock |  |  | 102 |  |  |  | 160 |  |
Range of exercise prices of such options |  | $0.69 - $5.50 |  |  | $1.85 - $7.02 |  |
The above options, which were outstanding at May 1, 2021, expire from January 31, 2023 to March 9, 2031. Excluded from the computation of basic and diluted earnings per share for both periods were 720,000 shares of unvested performance stock units. These performance-based awards will be included in the computation of basic and diluted earnings per share if, and when, the respective performance targets are achieved. In addition, 435,568 shares and 335,073 shares of deferred stock at May 1, 2021 and May 2, 2020, respectively, were excluded from basic earnings per share. Outstanding shares of deferred stock are not considered issued and outstanding until the vesting date of the deferral period.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration